Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

PYM 50018

Next Previous
X
Search
Drug Profile

PYM 50018

Alternative Names: Myogane; P 59; PYM50018

Latest Information Update: 16 Jul 2016

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Phytopharm
  • Developer IXICO; Phytopharm
  • Class Neuroprotectants; Small molecules; Steroid sapogenins
  • Mechanism of Action Brain derived neurotrophic factor agonists; Glial cell line-derived neurotrophic factor agonists; Neuron stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Amyotrophic lateral sclerosis
  • New Molecular Entity Yes
  • Available For Licensing Yes - Amyotrophic lateral sclerosis; Neurodegenerative disorders

Highest Development Phases

  • No development reported Amyotrophic lateral sclerosis; Glaucoma

Most Recent Events

  • 16 Jul 2016 No recent reports of development identified for preclinical development in Glaucoma in United Kingdom (PO)
  • 23 May 2013 Phytopharm conducts discussions with external parties for further development of PYM 50018 under licensing arrangements
  • 04 Oct 2011 Phytopharm receives a grant from the Technology Strategy Board for PYM 50018 development in Glaucoma

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top